Thommen Chacko

Thommen Chacko possesses extensive experience in the pharmaceutical and biotechnology sectors, having held prominent roles at Bristol Myers Squibb, including General Manager for BMS Sweden and Vice President for US & WW Commercial Strategy, Performance & Forecasting. Prior positions include Director of WW Oncology Forecasting & Strategic Planning at Bristol Myers Squibb and various analytical roles at IMS Health and PharmARC, where expertise was developed as a Consultant, Analyst, and Senior Business Analyst. Thommen Chacko began the professional journey with a summer internship at Panacea Biotech. Education was completed at SIES College of Management Studies, where a PGDM in Biotechnology Management was earned from 2008 to 2010.